Adjacent markets Soliton’s RAP platform targets non-invasive aesthetic procedures for cellulite and tattoo removal, presenting cross-sell opportunities with clinics offering laser tattoo removal and cellulite treatment services.

Acquisition signals Historical acquisition activity around Soliton suggests high strategic interest from larger players in aesthetic devices; position messaging to potential partners about scale benefits and potential integration with existing portfolios.

Early market Current US clearance for cellulite and tattoo removal indicates early-stage adoption; tailor outreach to clinics seeking differentiated, non-invasive technologies to attract patients and reduce treatment costs.

Clinical leverage University of Texas and MD Anderson licensing may support credibility; use in discussions with research hospitals and medical groups to open pilot programs and value-based procurement conversations.

Growth readiness Small team size with notable funding and a recent history of leadership hires signals agility; propose partnerships with OEMs or distributors to extend product reach and accelerate revenue generation.